✦ LIBER ✦

Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between fixed dose and an individually adjusted dose of a low molecular weight heparin

✍ Scribed by David Warwick

Book ID: 114040187
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 122 KB
Volume: 28
Category: Article
ISSN: 0020-1383
DOI: 10.1016/s0020-1383(97)90037-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thromboembolic prophylaxis in orthopaedi

Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (nadroparin calcium)

✍ P. Haentjens 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 883 KB

Heparin/dihydroergotamine for venous thr

Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery

✍ Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. Møller-Larsen; V. E. Knud 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo

Low dose heparin versus low molecular we

Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin®) in the prophylaxis of thromboembolic complications of abdominal oncological surgery

✍ J.-P. FRICKER; Y. VERGNES; R. SCHACH; A. HEITZ; M. EBER; L. GRUNEBAUM; M.-L. WIE 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

Fixed-dose low-molecular-weight heparin

Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study

✍ M. Monreal; L. Zacharski; J. A. Jiménez; J. Roncales; B. Vilaseca 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Dose escalation of low molecular weight

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients

✍ M. CARRIER; G. LE GAL; R. CHO; S. TIERNEY; M. RODGER; A. Y. LEE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB